Cargando…
Cholesterol-enriched membrane micro-domaindeficiency induces doxorubicin resistancevia promoting autophagy in breast cancer
Drug resistance has become one of the largest challenges for cancer chemotherapies. Under certain conditions, cancer cells hijack autophagy to cope with therapeutic stress, which largely undermines the chemo-therapeutic efficacy. Currently, biomarkers indicative of autophagy-derived drug resistance...
Autores principales: | Shi, Yin, Ye, Zu, Lu, Guang, Yang, Naidi, Zhang, Jianbin, Wang, Liming, Cui, Jianzhou, del Pozo, Miguel A., Wu, Yihua, Xia, Dajing, Shen, Han-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573103/ https://www.ncbi.nlm.nih.gov/pubmed/34786475 http://dx.doi.org/10.1016/j.omto.2021.10.005 |
Ejemplares similares
-
Curcumin targets the TFEB-lysosome pathway for induction of autophagy
por: Zhang, Jianbin, et al.
Publicado: (2016) -
Importance of ROS-mediated autophagy in determining apoptotic cell death induced by physapubescin B
por: Xu, Jian, et al.
Publicado: (2017) -
Autophagy and Tumor Database: ATdb, a novel database connecting autophagy and tumor
por: Chen, Kelie, et al.
Publicado: (2020) -
Cholesterol‐enriched membrane rafts and insulin secretion
por: Dirkx Jr, Ronald, et al.
Publicado: (2012) -
Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19
por: Yang, Naidi, et al.
Publicado: (2020)